Canopy Growth 1Q Loss Narrows on Cannabis, Vaporizer Strength

Dow Jones08-07 19:41
 
 

Canopy Growth' logged a narrowed loss in its fiscal first quarter as cannabis sales rose and new vaporizer products boosted revenue.

For the three months ended June 30, the cannabis company posted on Friday a narrowed net loss of 14.6 million Canadian dollars ($10.4 million), or C$0.03 a share, compared with a loss of C$44.9 million, or C$0.24 a share, in the comparable quarter a year ago.

According to FactSet, analysts were expecting a loss of C$0.06 a share.

Adjusted loss before interest, taxes, depreciation and amortization also narrowed, reaching C$3.2 million from a loss of C$7.9 million.

Consolidated net revenue rose 13% to C$81.2 million, but came in shy of analyst forecasts of C$82.7 million.

The growth was due to a 14% increase in cannabis revenue, which generated C$65.1 million driven by both medical and adult-use cannabis strength, with growth in its international markets as well.

At the company's vaporizer business, Storz & Bickel, net revenue rose 6%, citing a larger lineup of products and higher sales in non-core markets.

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment